Background. Increasing recipient and donor age are independently associated with survival after liver transplantation (LT). Whether donor age differentially impacts post-LToutcomes based on recipient age is unknown. Methods. This was a retrospective cohort study using Organ Procurement and Transplantation Network data. All adult deceased-donor, single organ, primary LTs from 2002 to 2015 were included. Donor and recipient age were categorized as younger than 40 years, 40 to 59 years, and 60 years or older. Mixed-effects survival analysis evaluated the risk of graft failure and death according to the interaction of donor and recipient age categories. Results. Of 63628 LTs, 6.6% were in recipients younger than 40 years, of which 51.4% used an age-matched donor younger than 40 years. There was a significant among-center variability unrelated to United Network for Organ Sharing region in the use of older organs in young recipients, ranging from 0% to 25% or greater (overall center median, 9.7%; interquartile range, 5.4-16.5%). There was a significant interaction between donor and recipient age (P < 0.05) such that the impact of older donor age was more pronounced in younger recipients. Transplanting livers from donors aged 40 to 59 years and 60 years or older was associated with worse graft survival in recipients younger than 40 years, but there was no difference based on donor age in recipients 60 years or older. Conclusions. There is a differential impact of using older donors in younger recipients than that in older recipients. Given their longer expected post-LT survival and the ethical imperative to maximize utilization of the scarce resource of transplantable livers, efforts should be made to allocate the highest-quality organs to those most likely to derive lasting benefit.
Background. Increasing recipient and donor age are independently associated with survival after liver transplantation (LT). Whether donor age differentially impacts post-LToutcomes based on recipient age is unknown. Methods. This was a retrospective cohort study using Organ Procurement and Transplantation Network data. All adult deceased-donor, single organ, primary LTs from 2002 to 2015 were included. Donor and recipient age were categorized as younger than 40 years, 40 to 59 years, and 60 years or older. Mixed-effects survival analysis evaluated the risk of graft failure and death according to the interaction of donor and recipient age categories. Results. Of 63628 LTs, 6.6% were in recipients younger than 40 years, of which 51.4% used an age-matched donor younger than 40 years. There was a significant among-center variability unrelated to United Network for Organ Sharing region in the use of older organs in young recipients, ranging from 0% to 25% or greater (overall center median, 9.7%; interquartile range, 5.4-16.5%). There was a significant interaction between donor and recipient age (P < 0.05) such that the impact of older donor age was more pronounced in younger recipients. Transplanting livers from donors aged 40 to 59 years and 60 years or older was associated with worse graft survival in recipients younger than 40 years, but there was no difference based on donor age in recipients 60 years or older. Conclusions. There is a differential impact of using older donors in younger recipients than that in older recipients. Given their longer expected post-LT survival and the ethical imperative to maximize utilization of the scarce resource of transplantable livers, efforts should be made to allocate the highest-quality organs to those most likely to derive lasting benefit. T he decision to accept an allograft for a given liver transplant (LT) candidate varies at the level of the transplant center. 1, 2 In research, the Donor Risk Index (DRI) has widely been used to help standardize the evaluation of organ quality; however, it is an imperfect clinical tool because the DRI can only be calculated once LT is completed (due to the inclusion of cold ischemic time). 3 As a result, the decision making regarding organ quality at the time of an organ offer cannot involve a full objective assessment of donor-recipient suitability. Though the LT allocation system does not formally account for transplant benefit, physicians often informally assess candidates' expected post-LT versus continued waitlist outcomes when an organ becomes available, particularly if the allograft is imperfect. In 2014, the US kidney transplant allocation scheme was revised to include a more uniform measurement of organ quality using the Kidney Donor Profile Index (KDPI). This, in combination with an evaluation of candidate expected posttransplant survival (EPTS), allows for the highest quality organs to be allocated to those most likely to derive long-term benefit. 4 The greatest factors influencing KDPI and EPTS are donor and recipient age, respectively. Specifically, kidney transplant candidates in the top 20th percentile of EPTS are preferentially allocated organs at the top 20th percentile of KDPI. Although such a system does not exist in LT, donor age and organ donation after circulatory determination of death (DDCD) are 2 of the strongest donor factors taken into consideration when an organ becomes available. These donor factors are most heavily weighted in the DRI of whole livers because they strongly predict graft survival. 3 Several authors have shown that certain candidates may be prone to worse outcomes with lowerquality organs, suggesting a need for a more formal method to match candidates and donor organs in LT. [5] [6] [7] [8] Given the persistent organ shortage, there is a clinical and ethical imperative to consider utility in the allocation of transplantable livers so as to maximize graft-years from this scarce resource. As the proportion of older recipients has markedly increased over time, younger candidates could potentially be disadvantaged from receiving the highest quality organs. 9 Yet, any alterations of the LT allocation system that seeks to optimize outcomes in young recipients should also do so without harming older recipients. Despite donor age being a well-studied risk factor for graft failure, prior singlecenter studies attempting to optimize post-LT outcomes by matching donor and recipient age have led to conflicting results. [10] [11] [12] [13] To further refine the current LT allocation scheme, a better understanding of the potential harm of increasing donor age is needed. The aims of this study are as follows: (1) to describe temporal trends and center variability in the use of older organs in young recipients; (2) to evaluate the interaction of donor and recipient age on the risk of death and graft failure after LT; (3) to explore the effect of reallocating older organs to older recipients on post-LT outcomes.
MATERIALS AND METHODS
This was a retrospective cohort study using the Organ Procurement and Transplantation Network (OPTN)/United Network for Organ Sharing (UNOS) database. All adult deceased-donor LTs from February 27, 2002, the start date of the Model for End-stage Liver Disease (MELD) allocation system, through December 31, 2015, were included. Patients were excluded if they underwent multiorgan transplants, retransplantation, or LT as a result of status 1 priority.
Donor and recipient age were evaluated as categorical, rather than continuous, variables to facilitate the interpretation of the effect of their interaction on post-LT outcomes. The following donor and recipient age categories were created: younger than 40 years, 40 to 59 years, and 60 years or older. The lower cutpoint of 40 years was selected as the DRI increases with increasing donor older than 40 years. 3 The upper cutpoint of 60 years was selected, as it has been used in prior studies evaluating outcomes of matching donor and recipient age. [10] [11] [12] Clinical and demographic characteristics according to recipient younger than 40 years versus 60 years or older were compared using χ 2 , Rank sum, and Kruskal Wallis tests. Temporal trends and center variability in the matching of donor and recipients according to age were examined. The effect of donor age on unadjusted recipient patient survival was evaluated with Kaplan-Meier curves and log-rank tests.
Multilevel mixed-effects parametric survival analysis clustered by transplant center using a Weibull distribution was used to model the risk of graft failure and post-LT mortality with the interaction of recipient and donor age as the primary exposure. Graft failure was defined as retransplantation or death. All models were additionally adjusted for the following pre-LT confounders and risk factors: (1) recipient age, race/ ethnicity, liver disease etiology, receipt of exception points, ascites severity, encephalopathy grade, patient location at LT, dialysis at LT, mechanical ventilation at LT, prior abdominal surgery, laboratory MELD score at LT, albumin at LT, Karnofsky Performance Score at LT; (2) donor cause of death, gender, race/ ethnicity, DDCD status, share type, split versus whole organ.
As an exploratory analysis, the effect of reallocating organs younger than 40 years to recipients younger than 40 years on post-LT survival was determined. Recipients younger than 40 years and 60 years or older were separated into distinct cohorts. Each cohort was replicated twice to create 2 additional hypothetical subcohorts for recipients younger than 40 and 60 years or older, in whom donor ages could be altered to study the effects of 2 different reallocation schemes. In the first scheme, only donors 60 years or older were reallocated from recipients younger than 40 years to recipients 60 years or older, in exchange for donors younger than 40 years. In the second scheme, donors 40 to 59 years and 60 years or older were reallocated from recipients younger than 40 years to recipients 60 years or older, in exchange for donors younger than 40 years. The multilevel mixed-effects model described was then applied to the original subcohort for recipients younger than 40 years and 60 years or older, which yielded in-sample predicted survival function estimates adjusted for recipient and donor covariates. Out-of-sample, adjusted predicted survival function estimates were then obtained from the 2 additional subcohorts, in which donor ages had been changed to study the effect of reallocating organs according to donor age on post-LT survival.
This study received exempt approval by the institutional review board at the University of Pennsylvania. All analyses were conducted using Stata version 14 (College Station, TX).
RESULTS
During the study period, 63628 LTs were performed, of which 6.6% were in recipients younger than 40 years, 61.7% in recipients aged 40 to 59 years, and 31.8% in recipients 60 years or older. Compared with recipients 60 years or older, recipients younger than 40 years had more advanced liver disease (median calculated MELD score, 23; interquartile range [IQR], 16-31 vs 17; IQR, 11-25; P < 0.001). They also had greater overall severity of illness at LT, with a higher proportion on dialysis (8.1% vs 6.7%; P = 0.002), on mechanical ventilation (4.8% vs 2.8%; P < 0.001), in the intensive care unit (12.8% vs 8%; P < 0.001) or with Karnofsky Performance Status score 10% to 40% (32.2% vs 25.6%; P < 0.001). On the other hand, recipients younger than 40 years were significantly less likely to have hepatocellular carcinoma (1.4% vs 43%; P < 0.001). They were also significantly less likely to receive a DDCD organ (3.7% vs 5.8%; P < 0.001).
Of 4174 recipients younger than 40 years, only 51.4% received an age-matched donor younger than 40 years. Thus, of 27855 available organs younger than 40 years, only 7.7% were allocated to age-matched recipients younger than 40 years. On the other hand, 40.9% of 8266 recipients 60 years or older received a donor younger than 40 years. In recipients 60 years or older transplanted for hepatocellular carcinoma versus other reasons, there was no clinically significant difference in the distribution of donor age (41.6% vs 40.5% received a donor liver <40 years; 19.5% vs 22% received a liver ≥60 years; P < 0.001). In addition, the distribution of donor age changed statistically over time, albeit not in a clinically meaningful manner: in 2002, 48.8% of transplanted livers were from donors younger than 40 years vs 46.1% in 2015, whereas 15.6% versus 15.7% were from donors 60 years or older (P < 0.001). Although the proportion of recipients 60 years or older doubled from 2002 to 2015 (21.1% to 44.7%), that of recipients younger than 40 years remained stable (7.8% to 7.6%; P < 0.001). Although there was a statistically significant difference in the calculated DRI based on recipient age (P < 0.001), these differences were not clinically significant: (a) recipient age < 40, median DRI: 1.35, IQR: 1.14-1.65; b) recipient age 40-59, median DRI: 1.40, IQR: 1.16-1.72; and c) recipient age ≥ 60, median DRI: 1.45, IQR: 1.18-1.79.
Of the 102 LT centers performing a minimum of 100 LTs during the study period (25th percentile), a median of 34.5 (IQR, 18-56) were performed in recipients younger than 40 years. Within this subgroup, 76 LT centers performed at least 20 LTs in recipients younger than 40 years from 2002 to 2015 (25th percentile). Among these, the median proportion of recipients younger than 40 years receiving an agematched organ younger than 40 years was 48.4%, and ranged from 36.8% to 73.4%. The proportion of young recipients receiving an organ 60 years or older, ranged from 0% in 4 centers to 25% or greater in 3 centers (median, 9.7%; IQR, 5.4-16.5%). This center variation was independent of UNOS region, and there was no significant regional variation among centers in the proportion of recipients younger than 40 years receiving an organ younger than 40 years (P = 0.07) or 60 years or older (P = 0.1). Marked center variation in the use of donors younger than 40 years in recipients 60 years or older was also seen across UNOS regions.
The magnitude of the effect of increasing donor age on unadjusted post-LT survival was greater in recipients younger than 40 years versus 60 years or older (Figure 1) . The absolute difference in 5-year survival in recipients younger than 40 years was 10.7% when comparing those receiving organs younger than 40 years versus 60 years or older, whereas this difference was 5.7% for recipients 60 years or older. The increased risk of graft failure in the first year post-LT (death or retransplantation) as a function of increasing donor age was differential across the 3 recipient age categories (Figure 2) . Although the risk of graft failure was significantly lower among recipients in the youngest age group transplanted with a liver from a donor in the youngest age group (P < 0.001), the risk of graft failure was not different among the 3 recipient age groups when the donor was 60 years or older of age (P = 0.90).
The results of the multivariable model evaluating the risk of death and graft failure are shown in Table 1 . The interaction of donor and recipient age was statistically significant in both models (P < 0.001 for both). Adjusting for other recipient and donor covariates, within the recipient age group younger than 40 years, those receiving organs 60 years had an 89% higher risk of graft failure and 74% higher risk of post-LT mortality compared with recipients younger than 40 years receiving age-matched organs. On the other hand, within the recipient age group 60 years or older, the risk of graft failure was not different in those receiving organs 60 years or older, though these older organs were associated with a 37% increase in the risk of post-LT mortality compared with recipients 60 years or older receiving organs younger than 40 years. Based on the UNOS coding of the cause of graft failure, donors younger than 40 years who received an allograft 60 years or older were more likely to die of multisystem organ failure (31% of graft failures from multisystem organ failure) than recipients 60 years or older (17% of graft failures from multisystem organ failure; Figures S1a and S1b, SDC, http://links.lww.com/TP/B596). The younger recipients who died of multisystem organ failure had significantly higher MELD scores at transplant (median, 23; IQR, 16-34 in recipients <40 years vs 18 (13-25) in recipients ≥60 years).
For all recipients younger than 40 years to receive an agematched organ younger than 40 years, 2029 livers younger Table 2 . Reallocating organs younger than 40 years to recipients younger than 40 years produced a statistically significant increase in median predicted survival function in this group, adjusting for other donor and recipient covariates (P < 0.001). However, replacing the needed organs younger than 40 years with older organs in recipients 60 years or older produced no significant change in their median predicted survival function (P = 0.4). As a sensitivity analysis, we additionally recreated subcohorts for recipients younger than 40 years and 60 years or older that altered not only donor age, but also donor sex, race/ ethnicity, cause of death, share type, split vs whole organ, DDCD status and diabetes status. These provided results of the same magnitude as those presented here (Table S1 , SDC, http://links.lww.com/TP/B596).
DISCUSSION
The effect of donor age on posttransplant mortality differs according to recipient age and is greatest when young recipients receive older donor organs, even when adjusting for recipient severity of illness or other donor characteristics. Only half of LT recipients younger than 40 years receive an age-matched donor organ, representing a major inefficiency in the LT system. To maximize life-years gained through LT, while most efficiently using the scarce resource of donor organs, the LT allocation system should be revised in order to better allocate high-quality organs to younger LT candidates, similar to kidney transplants. Furthermore, reallocating livers younger than 40 years from older to younger candidates could potentially produce a significant increase in survival probability in young recipients without altering post-LT outcomes in older recipients.
During the study period, 27855 donor organs younger than 40 years were used, representing a majority (44%) of the available organ pool. Since candidates younger than 40 years represent a minority of LT recipients overall, only 7% of these high quality organs from young donors would need to be reallocated in order for all young candidates to receive an age-matched organ. An allocation scheme that takes into consideration donor and recipient age is already in place for pediatric LT candidates, who are prioritized ahead of adults for age-matched organs.
14 However, after LT candidates turn 18 years, this organ allocation advantage is lost. The issue of refining the LT allocation system to facilitate a more efficient use of the available organ pool has particular relevance today, given the doubling in LT recipients 60 years or older over the last decade, the stable proportion of recipients younger than 40 years, and an increase in the number of donors ages 18 to 39 years and a decrease in the median donor age as a result of the opioid epidemic. 15 It might be argued that young LT candidates cannot afford to wait for a high-quality organ to become available due to their increased severity of illness. Although this is likely to be an issue in some cases, their higher MELD scores should increase their waitlist priority and organs 60 years or older represent only 17% of the available organ pool. This suggests that center acceptance behaviors drive the decision to accept an older organ for a younger transplant candidate. This issue of differences in center practices is also highlighted in the fact that there is wide variability both in the likelihood to use agematched young donors and to use older donors in young recipients. Moreover, this center-specific practice variability did not correlate with UNOS region, and therefore with regional MELD variation or with organ supply and demand differences. The fact that younger recipients were less likely to receive a liver from a DCDD donor suggests there may be some nuanced donor-recipient matching; however, this may not be beneficial to these patients given recent data suggesting superior outcomes in recipients of a liver from a young, ideal DCDD donor compared with an "older" brain-dead donor. 16 Although this study provides important insights into the need for further refinement of the existing allocation system for LT, it also has several limitations. The use of retrospective administrative transplant data from UNOS precludes a detailed evaluation of the decision making involved when organs were accepted for specific candidates. Moreover, this work was not able to incorporate match run data, which could provide a better understanding of the quality of other organs available during the allocation process. In our exploration of the effects of reallocating younger organs from older to younger candidates, we did not change the other characteristics of each donor, though the out-of-sample survival distribution estimates did adjust for other donor covariates to account for this. Reassuringly, in sensitivity analyses where we recreated subcohorts that altered not only donor age, but also donor gender, race/ethnicity, cause of death, share type, split versus whole organ, DDCD status and diabetes status, the results were unchanged.
In conclusion, given the trends in population aging, there is a need for a refinement of the organ allocation process to avoid disadvantaging young LT candidates who have long EPTS. The kidney transplant community has successfully changed their practices to facilitate the use of higher quality organs in candidates likely to derive lasting benefit, and it is time for the LT community to consider doing the same. This research demonstrates the potential harms associated with the inefficiency of the current allocation system for LT and also calls for continued efforts in the study of optimal donor and recipient matching and center decision making practices.
